GB201000196D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
GB201000196D0
GB201000196D0 GBGB1000196.4A GB201000196A GB201000196D0 GB 201000196 D0 GB201000196 D0 GB 201000196D0 GB 201000196 A GB201000196 A GB 201000196A GB 201000196 D0 GB201000196 D0 GB 201000196D0
Authority
GB
United Kingdom
Prior art keywords
novel combination
novel
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1000196.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GALVEZ JULIAN M
Original Assignee
GALVEZ JULIAN M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GALVEZ JULIAN M filed Critical GALVEZ JULIAN M
Priority to GBGB1000196.4A priority Critical patent/GB201000196D0/en
Publication of GB201000196D0 publication Critical patent/GB201000196D0/en
Priority to PCT/GB2010/051109 priority patent/WO2011083291A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1000196.4A 2010-01-07 2010-01-07 Novel combination Ceased GB201000196D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1000196.4A GB201000196D0 (en) 2010-01-07 2010-01-07 Novel combination
PCT/GB2010/051109 WO2011083291A1 (en) 2010-01-07 2010-07-05 Combinations comprising an ant i -inflammatory agent and/or an antibacterial agent and a glycosylamine and their use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1000196.4A GB201000196D0 (en) 2010-01-07 2010-01-07 Novel combination

Publications (1)

Publication Number Publication Date
GB201000196D0 true GB201000196D0 (en) 2010-02-24

Family

ID=41819034

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1000196.4A Ceased GB201000196D0 (en) 2010-01-07 2010-01-07 Novel combination

Country Status (2)

Country Link
GB (1) GB201000196D0 (en)
WO (1) WO2011083291A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103054965B (en) * 2013-02-01 2014-06-18 张冠军 External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster
CA2970060C (en) * 2015-01-13 2023-10-03 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Combination of benzydamine and an antimycotic for the treatment of mycosis
CN112858690B (en) * 2021-01-21 2023-11-10 宁波职业技术学院 Urine albumin/urine creatinine composite quality control product and preparation method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA775085A (en) * 1963-07-18 1968-01-02 E. Underwood Gerald Anti-inflammatory compositions comprising topical anti-inflammatory glucocorticoids and topical antiviral nucleosides
AU8379182A (en) * 1981-06-04 1982-12-09 Procter & Gamble Company, The Composition of salicylates and purine derivatives
DE3301328A1 (en) * 1982-02-01 1983-08-11 The Upjohn Co., 49001 Kalamazoo, Mich. PRELIMINARY MEDICINAL CONTROL OF ACUTE OR CHRONIC, MYELOGENIC LEUKAEMIA
DE3521994A1 (en) * 1985-06-20 1987-01-02 Bayer Ag N- (2-AMINOACYLAMIDO-2-DESOXY-HEXOSYL) -AMIDES, CARBAMATES AND UREAS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
US5631245A (en) 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US20020103141A1 (en) * 1998-12-23 2002-08-01 Mckearn John P. Antiangiogenic combination therapy for the treatment of cancer
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
RU2191582C2 (en) * 2000-04-05 2002-10-27 Хазанов Вениамин Абрамович Pharmaceutical compositions based on nonsteroid anti-inflammatory agents
FR2812812B1 (en) * 2000-08-08 2002-10-11 Philippe Gorny MEDICINE INTENDED IN PARTICULAR TO COMBAT SEXUAL DYSFUNCTIONS
US20040157848A1 (en) * 2002-12-19 2004-08-12 Pharmacia Corporation Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
WO2006103702A2 (en) * 2005-04-01 2006-10-05 Mccullough Ricky W Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium
CN1771973A (en) * 2005-10-25 2006-05-17 张哲峰 Composite medicine containing nonsteroidal anti-inflammatory analgetic and its prepn
WO2007092936A2 (en) * 2006-02-08 2007-08-16 University Of Virginia Patent Foundation Method to treat gastric lesions
US7378401B2 (en) * 2006-07-14 2008-05-27 Heidelberg Pharma Gmbh Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases
GB0622688D0 (en) 2006-11-14 2006-12-27 Diosamine Dev Corp Novel compounds
RU2361626C2 (en) * 2007-06-04 2009-07-20 Государственное образовательное учреждение высшего профессионального образования "Челябинская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию Российской Федерации" Way of local immunotherapy of septic wounds of maxillofacial area
GB2450087A (en) 2007-06-11 2008-12-17 Diosamine Dev Corp Use of sulphated saccharides in the treatment of inflammatory and/or auto-immune diseases
GB2450088A (en) * 2007-06-11 2008-12-17 Diosamine Dev Corp Optionally modified monosaccharides with imine/iminium or glycosidic amine/ammonium group for use in modifying the level of cytokines & in therapy

Also Published As

Publication number Publication date
WO2011083291A1 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2547244A4 (en) Combination juicer-blender
EP2566479A4 (en) Azaindazoles
EP2640189A4 (en) 3-deutero-pomalidomide
EP2534256A4 (en) Novel uses
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2651505A4 (en) Electroporation-induced electrosensitization
EP2641891A4 (en) Pkc- activator
GB201013207D0 (en) Novel combination
EP2572199A4 (en) Combination
IL225312A0 (en) Novel combinations
EP2571358A4 (en) Combination
GB201000196D0 (en) Novel combination
EP2603078A4 (en) Combination
EP2575460A4 (en) Combination
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
GB201013212D0 (en) Novel combination
GB201013209D0 (en) Novel combination
GB201013211D0 (en) Novel combination
GB201013214D0 (en) Novel combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)